# Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)

> **NCT00573001** · PHASE3 · COMPLETED · sponsor: **French National Agency for Research on AIDS and Viral Hepatitis** · enrollment: 120 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Tenofovir/Emtricitabine (Truvada) and Nevirapine
- **DRUG:** Tenofovir/Emtricitabine/Efavirenz (Atripla)
- **DRUG:** Tenofovir (Viread) and Lopinavir/Ritonavir (Aluvia)
- **DRUG:** Tenofovir/Emtricitabine (Truvada) and Zidovudine

## Key facts

- **NCT ID:** NCT00573001
- **Lead sponsor:** French National Agency for Research on AIDS and Viral Hepatitis
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2011-07
- **Final completion:** 2011-12
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2012-05-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00573001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00573001, "Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00573001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*